Drugs / injectable platelet-rich fibrin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05283668 | Feb 2020 → Jan 2022 | gingival disorder | Ain Shams University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | injectable platelet-rich fibrin | “OBJECTIVE: To determine whether intra-mucosal injection of injectable platelet-rich fibrin (i-PRF) can promote healing after Diode Laser Gingival Depigmentation (DLGD).” PMID 38536994 ↗ Mar 2024 |
| Known as | i-PRF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05283668 ↗ |
| Route | Other | “For each patient, two arch sites were randomly assigned for either intra-mucosal injection of i-PRF (G1-i-PRF) (n=10 sites) or no treatment (G2-Control): (n=10 sites).” PMID 38536994 ↗ Mar 2024 |